Timothy Doyle, MS

Operations Manager
JMI Laboratories

Disclosure(s): AbbVie: Grant/Research Support

Poster(s):

• 125 - Induction of Resistance Against Antipseudomonal Agents: Comparison of Novel b-Lactam/b-Lactamase Inhibitor (BL/BLI) Combinations and Other b-lactam Agents
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 664 - Increase in the Occurrence of Carbapenem-Resistant Enterobacterales (CRE) in United States (US) Hospitals from 2019 to 2021 and Activity of Novel b-Lactam/b-Lactamase Inhibitor (BL/BLI) Combinations Against These Isolates
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET